BPC-157 & TB-500: What the FDA’s July 2026 PCAC Vote Means

BPC-157 & TB-500 FDA Hearing July 2026: What It Means

Maybe you've heard that BPC-157 and TB-500 are now FDA-approved after the recent PCAC vote. They're not. The FDA's Pharmacy Compounding Advisory Committee did vote 8-6 to recommend these peptides for the compounding list, but that's an advisory recommendation inside a multi-step regulatory process. It's not approval for use. If you misread that distinction, you…

Read More